DONATE
Cal's Angels and the Violet Foundation Pledge $600,000 to the ChadTough Defeat DIPG Foundation to Co-Fund New Research Fellowships
We are thrilled to announce our latest research endeavor in the fight against pediatric cancer. In partnership with The Violet Foundation for Pediatric Brain Cancer, we have pledged $600,000 to the Chad Tough Defeat DIPG Foundation. We are funding two new fellowships to develop the next generation of leaders in DIPG research. One of the fellowships will be granted to Jiasen He of the University of Texas MD Anderson Cancer Center, mentored by Candelaria Gomez-Manzano. The second will be granted to Andrea Timpanaro of Seattle Children's Hospital, mentored by Nick Vitanza.
What are the facts about DIPG (Diffuse intrinsic pontine glioma)?
- Cancer is the #1 cause of children's death by disease, and brain cancer is the most lethal form.
- DIPG is the most lethal brain cancer, with an overall survival rate of less than 1%.
- There are some instances of longer-term survival, but the average survival for a child with DIPG or DMG is about 9-12 months.
- DIPG typically affects kids between the ages of 4 and 11, however, it can also affect younger and older children, including young adults.
In recent years, researchers' understanding of the biology of these tumors has significantly improved. Researchers now believe a cure for DIPG is within reach, which is why we are determined to contribute to the fight against this horrible disease.
To learn more about DIPG and the ChadTough foundation, visit chadtough.org. Learn more about The Violet Foundation at violet-foundation.org.
Cal's Angels funds Lurie Children's groundbreaking children's cancer research
Cal’s Angels partners with Lurie Children’s Hospital and Northwestern University Feinberg School of Medicine to create new treatments for children’s cancers and save more children’s lives.
READ MORE
Lurie's Update: December 2016
I would like to express my appreciation for the support and thoughtfulness Cal’s All-Star Angel Foundation has demonstrated in order to provide brighter futures for children and their families. Your investment is enabling us to obtain the necessary personnel and resources to pursue breakthrough research that will produce increasingly more individualized and effective treatments for our patients.
READ MORE
Lurie's Update: June 2017
Your support will accelerate our efforts in pediatric drug discovery, making it possible to bring new therapies from the laboratory to human clinical trials in a more efficient and cost-effective way.
READ MORE